Sign inJoin waitlistJoin the waitlist

LM

Leo Mascarenhas

, Director of Pediatric Hematology and Oncology · Cedars-Sinai Medical Center

Credentials: · · · ·

History

Pediatric Hematology and Oncology · Cedars-Sinai Medical Center
Present

Pediatric Hematology Oncology
Children's Hospital Los Angeles
1995–1998
Pediatrics
New York Medical College
1992–1995
St. John's Medical College
1987–1991

Research

Efficacy of Larotrectinib in TRK Fusion-Positive Cancers in Adults and Children
New England Journal of Medicine · 2018 · 2,193 citations
Larotrectinib in patients with TRK fusion-positive solid tumours: a pooled analysis of three phase 1/2 clinical trials
The Lancet Oncology · 2020 · 835 citations
Survival and prognosis with osteosarcoma: outcomes in more than 2000 patients in the EURAMOS-1 (European and American Osteosarcoma Study) cohort
European Journal of Cancer · 2019 · 537 citations

Rajkumar Venkatramani
36 papers
Douglas Hawkins
20 papers
Steven DuBois
16 papers
DR
Damon Reed
12 papers
Katherine Janeway
12 papers
Shengmei Zhou
12 papers
Patrick Leavey
10 papers
Theodore Laetsch
10 papers
Marcio Malogolowkin
9 papers
Larry Wang
8 papers
Smita Bhatia
8 papers · 6 as a resident
Wendy Landier
8 papers

Grants

General Clinical Research Center
National Center for Research Resources · M01
Project lead · $2.3K · University of Southern California
2008–2009

Clinical trials

Dose-Escalation Study of Pixantrone Monotherapy in Pediatric Patients With Relapsed or Refractory Cancer
Principal investigator · Withdrawn · Phase 1
CTI BioPharma
2016–2018
Durvalumab in Pediatric and Adolescent Patients
Principal investigator · Completed · Phase 1
Leo Mascarenhas
2016–2023
Vinorelbine Tartrate and Cyclophosphamide in Combination With Bevacizumab or Temsirolimus in Treating Patients With Recurrent or Refractory Rhabdomyosarcoma
Principal investigator · Completed · Phase 2
National Cancer Institute (NCI)
2010–2015
Two Regimens of Combination Chemotherapy in Treating Younger Patients With Newly Diagnosed Localized Ewing Sarcoma Family of Tumors
Principal investigator · Completed
Children's Oncology Group
2008